Table 3 Percent changes in weekly intravenous iron and subcutaneous erythropoietin-Alpha over 6 months and 12 months
Variables | Baseline (N, %) | After 6 months (N, %) | After 12 months (N, %) |
|---|---|---|---|
Subcutaneous Epoetin-Alpha (dose/week) | |||
No Epoetin alpha | 41 (12.3%) | 41 (12.3%) | 41 (12.3%) |
4000 IU/week | 149 (44.6%) | 228 (68.3%) | 293 (87.7%) |
8000 IU/week | 79 (23.7%) | 65 (19.5%) | 0 (0%) |
12,000 IU/week | 65 (19.5%) | 0 (0%) | 0 (0%) |
Intravenous iron sucrose (dose/week) | |||
Once/week | 137 (41%) | 268 (80.2%) | 334 (100%) |
Twice/week | 131 (39.2%) | 66 (19.8%) | 0 (0%) |
Thrice/week | 66 (19.8%) | 0 (0%) | 0 (0%) |